Literature DB >> 16186791

A novel link between Lck, Bak expression and chemosensitivity.

K Heyninck1, R Beyaert.   

Abstract

Protein kinases are critically involved in signaling pathways that regulate cell growth, differentiation, activation, and survival. Lck, a member of the Src family of protein tyrosine kinases, plays a key role in T-lymphocyte activation and differentiation. However, under certain conditions Lck is also involved in the induction of apoptosis. In this issue of Oncogene, Samraj et al. used the Lck-defective JCaM1.6 cell line to demonstrate the critical role of Lck in the apoptotic response of T-cell leukemia cells to several chemotherapeutic drugs. They further showed that Lck controls the mitochondrial death pathway by regulating proapoptotic Bak expression. This chemosensitizing effect of Lck is independent of T-cell receptor signaling and does not require the kinase activity of Lck. These findings demonstrate that Lck might be part of two independent signaling pathways leading to either cell proliferation or apoptosis, and reveal a hitherto unrecognized link between Lck, Bak, and chemosensitivity of human leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16186791     DOI: 10.1038/sj.onc.1209157

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Authors:  Gaofeng Fan; Matthew J Simmons; Sheng Ge; Jui Dutta-Simmons; Jérôme Kucharczak; Yacov Ron; David Weissmann; Chiann-Chyi Chen; Chandreyee Mukherjee; Eileen White; Céline Gélinas
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

2.  LCK, survivin and PI-3K in the molecular biomarker profiling of oral lichen planus and oral squamous cell carcinoma.

Authors:  Oluwadayo Oluwadara; Luca Giacomelli; Russell Christensen; George Kossan; Raisa Avezova; Francesco Chiappelli
Journal:  Bioinformation       Date:  2009-12-31

3.  Identifying critical non-catalytic residues that modulate protein kinase A activity.

Authors:  Eileen J Kennedy; Jie Yang; Lorraine Pillus; Susan S Taylor; Gourisankar Ghosh
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

4.  LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.

Authors:  Le Ge; Lixia Xu; Shan Lu; Hua Yan
Journal:  FEBS Open Bio       Date:  2020-04-13       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.